API- Maraviroc


Strength-150 mg, 300 mg

Get an Enquiry


Maraviroc is a CCR5 co-receptor antagonist used for the combination antiretroviral treatment of adults infected with only CCR5-tropic HIV-1 detectable, who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

Dosage and Side Effects

  • The recommended dose of Maraviroc differs on behalf of the concomitant medicines due to drug interactions. Maraviroc can be taken with or without food and must be given in combination with other antiretroviral medicines.
  • When Maraviroc given with strong CYP3A inhibitors (with
    or without CYP3A inducers) including PIs (except ritonavir and tipranavir), delavirdine, the recommended dose is Maraviroc 150 mg twice daily.
  • When given with NRTIs, tipranavir/ritonavir, nevirapine, and other drugs that are not strong CYP3A inhibitors or CYP3A inducers, the recommended dose is 300 mg twice daily.
  • When given with CYP3A inducers including efavirenz (without a strong CYP3A inhibitor), the recommended dose is 600 mg twice daily.

The most commonly reported Maraviroc side effects include: pyrexia, cough, upper respiratory tract infections, musculoskeletal symptoms, rash, abdominal pain, and dizziness.


Warning and Precautions

  • Use caution when administering maraviroc tablets to patients with pre-existing liver dysfunction or who are co-infected with viral hepatitis B or C.
  • Cardiovascular events including infarction and / or myocardial ischemia were noted in patients who received treatment with maraviroc. Use this drug with caution in patients at increased risk of cardiovascular events.
  • Patients should be monitored closely for evidence of infections while receiving maraviroc generic.
  • Immune reconstitution syndrome has occurred in patients taken treatment with combination antiretroviral therapy, including maraviroc. During the 1’st phase of combination antiretroviral therapy, patients whose immune system responds may establish an inflammatory response to indolent or residual opportunistic infections, which may necessitate further assessment and treatment.
  • Caution should be used when administering maraviroc tablets in patients with a history of postural hypotension or on concomitant medication known to lower blood pressure.


What is Maraviroc?

Maraviroc is an anti-HIV medication known as a CCR5 antagonist. It is used with other anti-HIV medicines in adults with CCR5-tropic HIV-1 infection who are already taking anti-HIV medicines and the medicines are not controlling their HIV infection.

What dosage strengths Maraviroc is supplied?

Maraviroc is supplied in two dosage strengths, which are as follows:

  • Maraviroc 150 mg
  • Maraviroc 300 mg

How is Maraviroc administered?

Maraviroc comes as tablets for oral administration. 

What type of medicine is Maraviroc? 

Maraviroc specifically is a type of medicine called HIV entry and fusion inhibitors. 

How much does Maraviroc cost?

Maraviroc is an HIV antiretroviral (ARV) aimed to treat HIV. The maraviroc cost is reasonably less and depends on a wide range of available brands including generic. Please contact us at 1800-889-1064 or send your enquiry at info

to find Maraviroc at the best cost.